Dr. Ricardo Rosselló is a scientist, author, professor, and former Governor of Puerto Rico. He now serves as Chief Visionary Officer of the Regenerative Medicine Institute (RMI Health). We spoke with him about RMI Health longevity science and the future of life extension.
Breakthroughs in aging research
Q: What is the biggest breakthrough in longevity research?
Moreover, RICARDO ROSSELLO: Cellular reprogramming can reverse biological aging. Shinya Yamanaka identified four genes that can reset cells to an embryonic-like state. This discovery opened the possibility of slowing or reversing aging at a fundamental level.
Moreover, Also, epigenetic clocks now help researchers measure biological age. They also support targeted interventions. The World Health Organization recognized aging as a disease in 2022. As a result, investment in the field has grown. RMI and its emerging longevity fund aim to improve both lifespan and healthspan.
Personalized medicine at RMI Health
Q: What advantages does personalized medicine offer patients?
Moreover, RICARDO ROSSELLO: Personalized medicine uses each person’s biological profile. Teams can review genomic data, gut microbiome composition, and epigenetic markers. They then create a customized “bio-blueprint” for longevity.
Moreover, Next, that plan can guide lifestyle changes and cellular therapies. It can also help RMI adjust treatments and improve patient outcomes.
Ethics, safety, and access
Q: How do you address ethical concerns around longevity research?
Moreover, RICARDO ROSSELLO: This question is central to our work. Novel therapies can produce exaggerated claims or even snake oil. Therefore, research and outcomes must come first. Every process needs rigorous clinical evaluation. Above all, treatments must be safe.
Moreover, However, current therapies can be expensive. However, that cost can help move procedures toward wider access. RMI’s long-term goal is to develop scalable and affordable therapies. The aim is to help people stay healthy and active for longer.
AI and predictive medicine
Q: How is RMI Health using AI to advance longevity science?
Moreover, RICARDO ROSSELLO: AI creates new possibilities. Digital twins, patient-specific solutions, and predictive medicine once sounded like science fiction.
Moreover, In addition, RMI collaborates with data scientists on predictive models. The team can optimize treatment protocols and identify therapeutic targets. AI also helps personalize interventions through genetic and epigenetic data.
The future of longevity science
Q: What role will RMI Health play in the future of longevity science?
Moreover, RICARDO ROSSELLO: We are at the dawn of a new era. A recent Time Magazine article covered gene therapy that could act as a “biological rewind button” for optic-nerve cells.
Moreover, Finally, the science is advancing. The next challenge is engineering and clinical application. There is a real race to reverse time at a cellular level. RMI hopes to help create a future where people live longer, healthier, and more vibrant lives.
